"Cholesterol, VLDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cholesterol which is contained in or bound to very low density lipoproteins (VLDL). High circulating levels of VLDL cholesterol are found in HYPERLIPOPROTEINEMIA TYPE IIB. The cholesterol on the VLDL is eventually delivered by LOW-DENSITY LIPOPROTEINS to the tissues after the catabolism of VLDL to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LDL.
| Descriptor ID |
D015243
|
| MeSH Number(s) |
D04.210.500.247.808.197.247 D10.532.599.700 D10.570.938.208.285 D12.776.521.622.700
|
| Concept/Terms |
Cholesterol, VLDL- Cholesterol, VLDL
- VLDL Cholesterol
- Pre-beta-Lipoprotein Cholesterol
- Cholesterol, Pre-beta-Lipoprotein
- Pre beta Lipoprotein Cholesterol
- Very Low Density Lipoprotein Cholesterol
- Prebetalipoprotein Cholesterol
- Cholesterol, Prebetalipoprotein
|
Below are MeSH descriptors whose meaning is more general than "Cholesterol, VLDL".
Below are MeSH descriptors whose meaning is more specific than "Cholesterol, VLDL".
This graph shows the total number of publications written about "Cholesterol, VLDL" by people in this website by year, and whether "Cholesterol, VLDL" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholesterol, VLDL" by people in Profiles.
-
Joshi PH, Khokhar AA, Massaro JM, Lirette ST, Griswold ME, Martin SS, Blaha MJ, Kulkarni KR, Correa A, D'Agostino RB, Jones SR, Toth PP. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies. J Am Heart Assoc. 2016 04 29; 5(5).
-
Adeyemo AA, Johnson T, Acheampong J, Oli J, Okafor G, Amoah A, Owusu S, Agyenim-Boateng K, Eghan BA, Abbiyesuku F, Fasanmade O, Rufus T, Doumatey A, Chen G, Zhou J, Chen Y, Furbert-Harris P, Dunston G, Collins F, Rotimi C. A genome wide quantitative trait linkage analysis for serum lipids in type 2 diabetes in an African population. Atherosclerosis. 2005 Aug; 181(2):389-97.
-
Yee WL, Wang Q, Agdinaoay T, Dang K, Chang H, Grandinetti A, Franke AA, Theriault A. Green tea catechins decrease apolipoprotein B-100 secretion from HepG2 cells. Mol Cell Biochem. 2002 Jan; 229(1-2):85-92.
-
Merkel M, Velez-Carrasco W, Hudgins LC, Breslow JL. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice. Proc Natl Acad Sci U S A. 2001 Nov 06; 98(23):13294-9.
-
V?lez-Carrasco W, Lichtenstein AH, Welty FK, Li Z, Lamon-Fava S, Dolnikowski GG, Schaefer EJ. Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion. Arterioscler Thromb Vasc Biol. 1999 Apr; 19(4):918-24.